Scripscan:Camlin Fine Chemical Ltd
BSE code:532834
cmp:90
Story:Camlin Fine Chemicals Ltd (CFCL) is engaged in manufacture of foodantioxidants and is involved in manufacture of Industrial Antiocidram.CHCL has a sweetner divison too which has developed an artificial sweetener,Sucralose,which is the new age sweetener having tremendous acceptability worldwide and with growing health awareness, which has an opportunity for immense growth.The business for the Sucralose has begun in South America, Europe,India and Central America. Dulcette Technologies LLC, a subsidiary of the Company in USA is developing the market for Sweetener in USA, Canada, and Mexico. Dulcette has launched Sucralose in US. The Company has already appointed an international expert for this product as the Company's employee to cover the European Union Market.It also manufactures the products required for stabilising Biodiesels.The world-wide demandis in excess of70 Million Metric Tons.The Company estimates volumes in excess of 1000 MT to be used for stabilising biodiesel produced and with growing needs,the market is set to grow at a tremendous pace.Chemolutions Chemicals Limited (CCL), a subsidiary of the Company has been formed along with a German national,which has over 25 years ofexperience in marketing specialty chemicals.It is a multiproduct manufacturing and marketing Company, having customer base spread across 45 countries worldwide including India and products having applications in processed foods, edible oils, paints, polymers, alternative fuels (biodiesel), rubber, health and pharmaceuticals.The food antioxidants segment is the biggest contributor to the company in terms of volume and growth and the company is also the world’s largest manufacturer of Food grade antioxidants, TBHQ and BHA with market share of about 35% world wide and 70% in India. CFCL has laid out an aggressive plan for increasing world wide market share above 50% by making an entry into growing food processing markets like Asia, Middle East and South America.Seeing the huge market potential for these products the company has already created adequate capacity for these products. This segment of the business is expected to contribute significantly from FY’11 onwards.CFCL has in the last three years grown at an average growth of 25%,and one can safely expect this growth to be maintained in the near future as it has ambitious products in the pipeline to be launched soon.At the current market price of Rs.90 CFCL’s projected FY 11E EPS of Rs. 13. is discounted 7x.Long term investors can add more of CFCL to their portfolio at dips.
Regards,
ARUN
I can be reached at:arunanalyst@rediffmail.com
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
